echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Merck's $17 billion acquisition of sigma Aldrich has been fully approved for antitrust

    Merck's $17 billion acquisition of sigma Aldrich has been fully approved for antitrust

    • Last Update: 2015-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Biovalley 2015-08-12 August 12, 2015, Merck KGaA recently announced that the US $17 billion cash acquisition of sigma Aldrich (hereinafter referred to as sigma), the world's largest chemical reagent producer, has been approved by antitrust authorities in all relevant jurisdictions

    The acquisition is expected to be completed in the third quarter of 2015

    Recently, the acquisition has been unconditionally approved by the Brazilian anti monopoly Agency (Cade), the last jurisdiction

    Before that, it was also approved by the anti-monopoly agencies of Israel and South Korea

    In the European market, Merck and sigma have agreed to sell part of Sigma's solvent and inorganic business in Europe according to the conditional approval issued by the European Commission (EC) on June 15

    The acquisition aims to enhance Merck millipore's experimental consumables business, expand Merck millipore's global coverage and improve its presence in North America and fast-growing Asian markets

    The acquisition of simga also marks a milestone of Merck's "transformation journey in 2018", transforming its three major businesses into sustainable growth platforms: healthcare, life sciences and high-performance materials

    On September 22 last year, the two sides reached a final acquisition agreement

    Merck will acquire Sigma with $17 billion in cash, thus becoming a leading company in the global life science industry with a value of $130 billion

    Merck will be able to provide a set of attractive mature brands and an efficient supply chain to global life science customers, which can support up to 30 Supply of more than ten thousand products

    In the laboratory & academic business, combined with Merck millipore and Sigma's existing life science business, Merck will provide a wide range of complementary products in laboratory chemicals, biological agents and reagents

    In terms of pharmaceuticals and biopharmaceuticals, Sigma will complement Merck millipore's existing products and capabilities

    It is worth mentioning that the acquisition of sigma is also the largest acquisition in Merck's history

    The biggest deal before was the $13.3 billion acquisition of Serono, Switzerland's largest biotechnology company, in 2007, which created a new giant in the European pharmaceutical industry and positioned it as a giant in the pharmaceutical industry

    However, Merck's research and development of new drugs have been repeatedly frustrated in the following years, and it has not launched any heavy-duty products, and now it is in trouble

    Then in 2010, Merck spent $6 billion to acquire millipore, a US laboratory equipment and chemicals manufacturer, to accelerate the transformation of the company

    Sigma Aldrich is a leading group company of life science and high technology in the world

    Its biochemical and organic chemical products and kits are widely used

    It has operations in 36 countries and regions

    Merck group is mainly committed to innovative pharmaceutical, life science and cutting-edge functional materials technology, with 154 branches in 67 countries and regions around the world

    Both have branches or joint ventures in China.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.